CarboCode S.A
Latest round
- Series C
Last raised
- Dec 2024
Total raised
- $16M
Investors
- 1
About CarboCode S.A
Established in 2017 and based in Portugal, CarboCode Germany GmbH operates as a biotechnology company that researches, develops, and manufactures clinical evidence and enzyme technology for human sphingolipid production. The company's primary offerings include a range of ceramides aimed at improving skin health and addressing major skin disorders, human milk gangliosides for infant nutrition, and human brain gangliosides that support cognitive functions and neuronal plasticity. These products are formulated using innovative biotechnology and chemistry, allowing for scalable production while ensuring they meet the physiological needs of the human body. CarboCode's client base includes manufacturers of skin care products and infant formula, as well as pharmaceutical companies, primarily targeting markets in Europe, North America, and Asia, where the demand for biologically relevant ingredients in health products is rapidly growing. CarboCode generates revenue through partnerships with companies in the skin care, infant nutrition, and cognitive health sectors, facilitating a business model centered around B2B transactions. The company engages in direct sales and distribution agreements with manufacturers and formulators who incorporate its sphingolipid products into their offerings. The company is strategically planning to introduce new products to enhance its portfolio and expand into markets in North America and Asia by the end of 2025.
Who invested in CarboCode S.A
1 investor across 1 round
See all investors in CarboCode S.A
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Funding rounds
Series C
Dec 4, 2024
Amount
$16M
Investors
Questions about CarboCode S.A
Who invested in CarboCode S.A?
CarboCode S.A has 1 investor on record across 1 venture round. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has CarboCode S.A raised?
CarboCode S.A has raised 1 venture round. Sign up free to see how much each round raised and the total.
When did CarboCode S.A last raise money?
CarboCode S.A's most recent round on record is a Series C, in Dec 2024.
What does CarboCode S.A do?
Established in 2017 and based in Portugal, CarboCode Germany GmbH operates as a biotechnology company that researches, develops, and manufactures clinical evidence and enzyme technology for human sphingolipid production.
Where is CarboCode S.A headquartered?
CarboCode S.A is headquartered in Cantanhede, Portugal.
Which VCs invest in companies like CarboCode S.A?
Among active investors with capital left to deploy, Index Ventures, Forbion, European Investment Bank and Generation Investment Management back biotechnology companies at CarboCode S.A's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series C
Raising like CarboCode S.A? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.